(Alliance News) - RTW Biotech Opportunities Ltd on Friday noted that portfolio firm BioAge Labs Inc has completed a USD198 million initial public offering.

BioAge Labs stock rose Thursday on the company's upsized IPO — reflecting enthusiasm for its approach to obesity treatments.

Anyone who follows Ryan Reynolds knows he is much more than just a Hollywood A-lister; he is a savvy entrepreneur with a ...

London, UK-based Vicebio raised $100 million in a Series B that will help to fund the development of its Molecular Clamp ...

Biotech IPOs are on the rise as interest rates fall, signaling a potential recovery for the sector. Read more here.

In the HY primary two issues were priced totaling US$1.2bn, lifting weekly supply to US$9.195bn and September volume to US$36.625bn, according to IFR data. The average IG bond spread was unchanged at ...

The target of the strike in Lebanon was the group’s leader, Hassan Nasrallah, according to Israeli and American officials. The attack came shortly after the Israeli prime minister gave a defiant ...

The veteran lawmaker also submitted public comment to the Food and Drug Administration as… The number of outbreaks and people sick in them in the Netherlands has gone down compared to the ...

Albert Duka, 33, was arguing with his 62-year-old father, Adzi Duka, when he punched the ...

Former Canadian politician suspected of working for foreign government: CSIS Former Canadian politician suspected of working for foreign government: CSIS Canada’s intelligence community released ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...